CAPE has been well studied in previous researches, including its MDR1 gene down-regulating effects in MCF-7 and MDA-MB-231 breast cancer cells [34] and P-gp inhibitory effects in HeLa resistant cancer subline and human intestinal LS174T cell line [35,36]. Here, PGP is linked to cancer.